Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B Without Inhibitors
Latest Information Update: 11 Jun 2025
At a glance
- Drugs Concizumab (Primary)
- Indications Haemophilia A; Haemophilia B
- Focus Registrational; Therapeutic Use
- Acronyms explorer8
- Sponsors Novo Nordisk
Most Recent Events
- 06 Jun 2025 According to Novo Nordisk media release, data from this trial will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) Congress, June 21-25.
- 25 May 2025 Planned number of patients changed from 158 to 156.
- 13 Apr 2025 Planned End Date changed from 9 Jun 2026 to 21 Feb 2028.